-

Margaret M. Crotty Elected Chair of Northwell Health Board of Trustees

Margaret M. Crotty is first woman to chair Northwell’s board;
takes reins following Michael Epstein’s four-year tenure

NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--The Northwell Health Board of Trustees on June 1, 2023, elected Margaret Crotty of New York as its new chair. She is the first woman to serve as Chair and succeeds Michael Epstein, who served for four years as chair of the 37-member board.

Ms. Crotty has served as a Northwell trustee since 2019. She is president and CEO of JSI, a global non-profit public health organization that manages large-scale public health, education, supply chain, and health system strengthening projects in 40 countries; and consults on health equity issues for federal, state and local governments in the US. She previously served as CEO of Partnership with Children, a New York City-based provider of community and school-based behavioral health. Before that, Ms. Crotty launched and led Save the Children’s flagship initiative to reduce global child and maternal mortality.

“Margaret is the right person at the right time to lead our board,” said Michael J. Dowling, president and CEO of Northwell Health. “She is an incredibly esteemed executive, familiar with the complexities of healthcare delivery, and passionate about improving the health of individuals and communities around the world. She has been a good friend of the health system for over eight years and will be a tremendous asset to our leadership team as we continue our efforts to raise the health of the diverse communities we serve.”

Ms. Crotty graduated from Princeton University with a BA in History and African-American Studies, and earned an MBA from Harvard Business School and a Masters in Public Health from Columbia University. She serves on several health and education boards, including those of the Open Medical Institute, the CUNY School of Public Health, the United Hospital Fund, and ACCESS Health International. She is a member of the Council on Foreign Relations and serves on several government task forces and higher education advisory boards.

“I am deeply honored to be elected chair of Northwell’s Board of Trustees at this critical time for healthcare, and to follow in the footsteps of remarkable leaders whose vision has helped build New York’s largest integrated health system. It will be my privilege to continue to advance the health system’s commitment to excellence, innovation and health equity – and I am excited to support Northwell’s future as board chair.”

About Northwell Health

Northwell Health is New York State’s largest health care provider and private employer, with 21 hospitals, about 900 outpatient facilities and more than 12,000 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 84,000 employees – 18,900 nurses and 4,900 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Twitter, Instagram and LinkedIn.

Contacts

Barbara Osborn
516-321-6777
bosborn@northwell.edu

Northwell Health


Release Versions

Contacts

Barbara Osborn
516-321-6777
bosborn@northwell.edu

More News From Northwell Health

Feinstein Institutes’ Research Pinpoints Core Cause of Vascular Cognitive Impairment, Unlocking New Therapeutic Avenues for Cognitive Decline

MANHASSET, N.Y.--(BUSINESS WIRE)--Scientists at Northwell Health’s Feinstein Institutes for Medical Research have uncovered a critical mechanism driving vascular cognitive impairment (VCI), the world’s second most common form of dementia after Alzheimer’s disease. Their findings, published this month in Alzheimer’s & Dementia, pinpoint the dysregulation of vasoactive neuropeptides, or key regulators of blood-vessel tone, as the root cause of microvascular dysfunction in VCI. This discovery...

Feinstein Institutes Awarded $4M Grant to Develop AI-Powered Speech Based ‘Vital Signs’ to Improve Psychosis Diagnosis and Treatment

MANHASSET, N.Y.--(BUSINESS WIRE)--Northwell Health’s Feinstein Institutes for Medical Research received $4 million from the National Institute of Mental Health (NIMH) to improve how severe mental health conditions are assessed and treated. By using an AI-powered advanced speech and language analysis, the research aims to develop personalized metrics to gauge the severity of psychosis. This research has the potential to transform the way patients with mental illness are diagnosed and treated, le...

Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience

MANHASSET, N.Y.--(BUSINESS WIRE)--Recent reports show that one in seven first responders have probable post-traumatic stress disorder (PTSD) in response to routine duties with prevalence increasing after responding to a crisis. To improve our understanding and the well-being of these essential heroes, researchers at Northwell Health’s Feinstein Institutes for Medical Research, Stony Brook University and Texas A&M University received a $3.37-million grant from the National Institute of Menta...
Back to Newsroom